Drugs / Clopidogrel active metabolite
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03774394 | Aug 2019 → May 2022 | chronic kidney disease, coronary artery disorder, type 2 diabetes mellitus | University of Florida | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clopidogrel active metabolite | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03774394 ↗ |